Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E74.79 EPS (ttm)0.06 Insider Own- Shs Outstand47.17M Perf Week2.30%
Market Cap209.91M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-
Income2.81M PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales26.26M P/S7.99 EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Book/sh0.82 P/B5.41 EPS next Y- ROA4.07% Short Interest- Perf Year-
Cash/sh0.02 P/C179.41 EPS next 5Y- ROE7.51% 52W Range3.70 - 6.10 Perf YTD-8.44%
Dividend Est.- P/FCF32.39 EPS past 5Y- ROI7.24% 52W High-27.05% Beta-
Dividend TTM- Quick Ratio0.81 Sales past 5Y-3.13% Gross Margin59.46% 52W Low20.27% ATR (14)0.79
Dividend Ex-Date- Current Ratio1.34 EPS Y/Y TTM-55.43% Oper. Margin18.90% RSI (14)- Volatility8.86% -
Employees275 Debt/Eq0.31 Sales Y/Y TTM-28.00% Profit Margin10.69% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-57.05% Payout- Rel Volume0.08 Prev Close4.35
Sales Surprise- EPS Surprise- Sales Q/Q-21.95% Earnings- Avg Volume485.51K Price4.45
SMA20-1.89% SMA50-1.89% SMA200-1.89% Trades Volume41,202 Change2.30%
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.